Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Axsome Therapeutics Stock Price (Quote) NASDAQ:AXSM
$40.10 ( -1.76% ) Friday, 22nd Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $29.71 | $42.83 | Friday, 22nd Oct 2021 AXSM stock ended at $40.10. This is 1.76% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 5.33% from a day low at $38.62 to a day high of $40.68. |
| 90 days | $19.38 | $54.30 | |
| 52 weeks | $19.38 | $87.24 |
Historical Axsome Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-22 | $40.05 | $40.68 | $38.62 | $40.10 | 484 661 |
| 2021-10-21 | $41.93 | $42.39 | $39.71 | $40.82 | 793 847 |
| 2021-10-20 | $40.41 | $42.50 | $39.91 | $41.91 | 641 168 |
| 2021-10-19 | $41.16 | $41.89 | $39.82 | $40.18 | 564 599 |
| 2021-10-18 | $39.80 | $41.26 | $37.23 | $41.12 | 1 233 551 |
| 2021-10-15 | $40.62 | $41.97 | $39.81 | $40.10 | 644 288 |
| 2021-10-14 | $41.63 | $42.42 | $39.57 | $40.62 | 1 549 678 |
| 2021-10-13 | $38.65 | $42.83 | $37.63 | $42.17 | 1 881 813 |
| 2021-10-12 | $32.60 | $37.80 | $32.27 | $37.79 | 1 395 879 |
| 2021-10-11 | $32.20 | $33.00 | $31.94 | $32.62 | 621 320 |
| 2021-10-08 | $31.74 | $32.64 | $31.63 | $32.20 | 566 652 |
| 2021-10-07 | $31.67 | $32.45 | $30.50 | $31.74 | 511 650 |
| 2021-10-06 | $31.30 | $31.64 | $30.10 | $30.85 | 662 985 |
| 2021-10-05 | $33.00 | $34.00 | $30.78 | $31.33 | 1 791 923 |
| 2021-10-04 | $34.22 | $34.74 | $32.23 | $32.63 | 881 548 |
| 2021-10-01 | $33.10 | $34.55 | $32.30 | $34.28 | 857 074 |
| 2021-09-30 | $34.03 | $34.17 | $30.70 | $32.96 | 1 240 368 |
| 2021-09-29 | $33.66 | $36.22 | $33.46 | $34.17 | 989 879 |
| 2021-09-28 | $34.65 | $34.99 | $32.29 | $33.23 | 884 307 |
| 2021-09-27 | $33.55 | $34.98 | $33.32 | $34.65 | 802 975 |
| 2021-09-24 | $32.54 | $34.41 | $32.54 | $33.40 | 985 352 |
| 2021-09-23 | $31.20 | $32.99 | $31.00 | $32.96 | 827 721 |
| 2021-09-22 | $31.56 | $31.60 | $29.71 | $30.89 | 1 101 110 |
| 2021-09-21 | $29.55 | $31.89 | $29.20 | $31.21 | 1 169 530 |
| 2021-09-20 | $28.98 | $29.55 | $28.52 | $29.23 | 890 312 |
| 2021-09-17 | $28.57 | $29.79 | $27.80 | $29.72 | 1 350 041 |
| 2021-09-16 | $27.63 | $29.37 | $27.61 | $28.53 | 1 182 163 |
| 2021-09-15 | $26.07 | $28.75 | $25.81 | $27.72 | 1 274 940 |
| 2021-09-14 | $28.45 | $28.85 | $25.79 | $26.17 | 1 968 658 |
| 2021-09-13 | $27.26 | $28.00 | $26.62 | $27.48 | 772 972 |
| 2021-09-10 | $27.11 | $27.68 | $26.11 | $27.39 | 942 666 |
| 2021-09-09 | $26.03 | $27.23 | $25.68 | $26.81 | 1 038 642 |
| 2021-09-08 | $26.51 | $26.51 | $25.03 | $26.14 | 689 858 |
| 2021-09-07 | $26.53 | $27.49 | $26.39 | $26.55 | 722 767 |
| 2021-09-03 | $26.87 | $27.32 | $26.12 | $26.69 | 720 838 |
| 2021-09-02 | $27.62 | $27.75 | $25.76 | $26.92 | 1 899 708 |
| 2021-09-01 | $25.95 | $28.28 | $25.63 | $27.71 | 2 207 835 |
| 2021-08-31 | $24.05 | $25.93 | $24.05 | $25.68 | 1 075 679 |
| 2021-08-30 | $24.31 | $24.90 | $23.71 | $24.38 | 875 601 |
| 2021-08-27 | $23.24 | $24.25 | $23.00 | $24.00 | 1 237 497 |
| 2021-08-26 | $25.20 | $25.79 | $22.85 | $23.26 | 1 573 920 |
| 2021-08-25 | $24.72 | $26.00 | $24.13 | $25.33 | 1 289 554 |
| 2021-08-24 | $25.09 | $25.19 | $23.48 | $24.89 | 2 561 483 |
| 2021-08-23 | $25.20 | $25.61 | $22.68 | $24.79 | 10 924 769 |
| 2021-08-20 | $19.89 | $21.97 | $19.70 | $21.56 | 1 616 544 |
| 2021-08-19 | $19.90 | $20.56 | $19.38 | $19.91 | 1 407 909 |
| 2021-08-18 | $21.06 | $21.33 | $20.11 | $20.30 | 1 250 713 |
| 2021-08-17 | $20.97 | $21.41 | $20.50 | $21.02 | 1 562 534 |
| 2021-08-16 | $22.79 | $22.86 | $21.10 | $21.22 | 1 783 694 |
| 2021-08-13 | $24.04 | $24.50 | $22.29 | $22.86 | 1 526 711 |
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of complex regional pain syndrome, knee osteoarthritis, and chronic low back pain; and AXS-05 that is in Phase III trial for the treatment of resistant depression and agitation in patients with Alzheimer's... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
